Progress in the prevention and control of viral hepatitis type B: Closing remarks

Alfredo Alberti, Maurizia Rossana Brunetto, Massimo Colombo, Antonio Craxì

Research output: Contribution to journalArticlepeer-review


Hepatitis type B remains an important disease globally. Rapid advances have been made during the last two decades in the understanding of the biology of HBV, the complex interaction between the virus and the host, and the pathology and the clinical aspects of infection. Mass vaccination has been shown to be a safe and highly effective means for the control and prevention of hepatitis B. The presence of a large worldwide reservoir of carriers requires a continuous effort to develop new drugs for the treatment of persistent HBV infection. Efforts to sustain immunization programs and to make vaccines and drugs available to countries with limited resources, are the main challenges to the eradication of hepatitis B in the next few decades.

Original languageEnglish
Pages (from-to)463-466
Number of pages4
JournalJournal of Medical Virology
Issue number3
Publication statusPublished - 2002


  • Epidemiology
  • HB therapy
  • HB vaccine
  • Hepatitis B
  • Prevention

ASJC Scopus subject areas

  • Virology


Dive into the research topics of 'Progress in the prevention and control of viral hepatitis type B: Closing remarks'. Together they form a unique fingerprint.

Cite this